36.35

0.00% +0.00

Fortrea Holdings Inc (FTRE)

Overview News Price History Option Chain Discussions Forecast

Fortrea Holdings Inc stock is currently priced at $36.35, with a 24-hour trading volume of 410.55K. It has seen a +0.00% increased in the last 24 hours and a -6.44% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $36.44 pivot point. If it approaches the $36.04 support level, significant changes may occur.

Previous Close:

$36.35

Open:

$36.27

24h Volume:

410.55K

Market Cap:

$3.25B

Revenue:

$3.11B

Net Income/Loss:

$-32.40M

P/E Ratio:

27.77

EPS:

1.3088

Net Cash Flow:

$127.10M

1W Performance:

+2.39%

1M Performance:

-6.44%

6M Performance:

+30.29%

1Y Performance:

+0.00%

1D Range:

$36.13

$37.07

52W Range:

$25.80

$41.02

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name

Fortrea Holdings Inc

Sector

Healthcare (1191)

Industry

Biotechnology (688)

Phone

877-495-0816

Address

8 Moore Drive, Durham

Employee

19,000

Twitter

Next Earnings Date

Latest SEC Filings

FTRE's Discussions on Twitter

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-24	Initiated	William Blair	Mkt Perform
Jan-04-24	Initiated	Jefferies	Buy
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Dec-01-23	Upgrade	Evercore ISI	In-line → Outperform
Nov-14-23	Upgrade	Barclays	Equal Weight → Overweight
Oct-19-23	Initiated	Citigroup	Neutral
Sep-14-23	Initiated	Evercore ISI	In-line
Aug-16-23	Initiated	Barclays	Equal Weight
Aug-07-23	Initiated	BofA Securities	Underperform

View All

Fortrea Holdings Inc Stock (FTRE) Latest News

Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call

GlobeNewswire Inc.

Where Fortrea Holdings Stands With Analysts

Benzinga

Fortrea ลงนามข้อตกลงขั้นสุดท้ายเพื่อขายธุรกิจ Endpoint Clinical และ Patient Access ให้กับพันธมิตร Arsenal Capital

GlobeNewswire Inc.

Company News for Mar 12, 2024

Zacks Investment Research

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

GlobeNewswire Inc.

Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday

Benzinga

Fortrea Holdings Inc Stock (FTRE) Financials Data

Fortrea Holdings Inc (FTRE) Revenue 2024

FTRE reported a revenue (TTM) of $3.11 billion for the quarter ending December 31, 2023, a +0.42% rise year-over-year.

Fortrea Holdings Inc (FTRE) Net Income 2024

FTRE net income (TTM) was -$32.40 million for the quarter ending December 31, 2023, a -116.80% decrease year-over-year.

Fortrea Holdings Inc (FTRE) Cash Flow 2024

FTRE recorded a free cash flow (TTM) of $127.10 million for the quarter ending December 31, 2023, a +283.99% increase year-over-year.

Fortrea Holdings Inc (FTRE) Earnings per Share 2024

FTRE earnings per share (TTM) was -$0.37 for the quarter ending December 31, 2023, a -116.96% decline year-over-year.

Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.